European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) 2025 Annual Meeting

September 24 - 26, 2025

NMOSD

html

A real-world study of the effectiveness and safety of ravulizumab in AQP4+ NMOSD patients with suboptimal response to satralizumab in Japan - interim analysis

html

Clinical and radiological outcomes in people with aquaporin-4 antibody positive neuromyelitis optica spectrum disorder following ravulizumab treatment (AMAZE)

pdf

Long-term efficacy and safety of ravulizumab in anti-aquaporin-4 antibody-positive neuromyelitis optica spectrum disorder: Final analysis of the phase 3 CHAMPION-NMOSD trial

pdf

Real-world clinical outcomes with eculizumab and ravulizumab in anti-aquaporin-4 antibody-positive (AQP4-Ab+) neuromyelitis optica spectrum disorder (NMOSD): results from the global NMO SPOTLIGHT Registry

Disclaimer

Some content may have changed since publication. Some links may require registration/login to access the content. Any attached publications and/or any tables or figures derived from the publications are copyright-protected works. AstraZeneca has obtained permission from the copyright owner to use this work on this site. You may not reproduce, prepare derivative works from, display or distribute this work unless you obtain the permission of the copyright owner, or as otherwise might be permitted by law.

Request a field medical follow-up

Welcome to AstraZeneca
Medical Information

The information provided on this site is intended for use by healthcare professionals practicing in the US. The dissemination of this information may be subject to different medical and regulatory requirements in other countries.

This web site is intended to help healthcare professionals practicing in the US and AstraZeneca authorized persons find scientifically balanced, evidence-based information about AstraZeneca drugs, submit a question, ask for field medical follow-up, and explore links to professional and patient support resources.

Are you a healthcare professional practicing in the United States?

I am an AstraZeneca authorized person

What is an AstraZeneca authorized person?This website is only intended for healthcare professionals practicing in the United States and authorized AstraZeneca personnel. AstraZeneca US Headquarters personnel and US Field Medical personnel are authorized to browse and search the database for their own background knowledge and insight. US Field Sales personnel should not access or browse this site. None of the content of this site should be directly linked or distributed without approval.

I am not a healthcare professional practicing in the United States (Take me to AstraZeneca.com)